Síntesis de Omeprazol para Inhibidores de la Bomba de Protones

Control del ácido gástrico con química de selección quiral

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Descripción general

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Proceso químico

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Materias primas

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Productos finales

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Consideraciones de seguridad

Innovaciones recientes

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Escala de producción

800

toneladas/año

$3.5 billion

valor de mercado

Más en Pharmaceutical & Drug Manufacturing

Producción de Insulina Humana Recombinante

Global Industrial Scale

Producción de Penicilina G por Fermentación

Global Industrial Scale

Producción Semi-Sintética de Amoxicilina

Global Industrial Scale

Síntesis de Aspirina por Acetilación del Ácido Salicílico

Global Industrial Scale

Síntesis de Clorhidrato de Metformina

Global Industrial Scale

Síntesis de Ibuprofeno — Proceso Verde BHC

Global Industrial Scale

Síntesis de Paracetamol (Acetaminofén)

Global Industrial Scale

Frequently Asked Questions

What industry uses Síntesis de Omeprazol para Inhibidores de la Bomba de Protones?
Síntesis de Omeprazol para Inhibidores de la Bomba de Protones is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Síntesis de Omeprazol para Inhibidores de la Bomba de Protones?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Síntesis de Omeprazol para Inhibidores de la Bomba de Protones?
Síntesis de Omeprazol para Inhibidores de la Bomba de Protones has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Síntesis de Omeprazol para Inhibidores de la Bomba de Protones?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Síntesis de Omeprazol para Inhibidores de la Bomba de Protones?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).